As a result, NEXUS AG was able to continue its positive development of the prior years both with respect to sales and result stably in 2014.

The Healthcare Software Division had sales growth of 8.5 % and increased from KEUR 64,940 in 2013 to KEUR 70,442 in 2014. The Healthcare Service Division achieved increased sales of 16.6 % with KEUR 9,705 (previous year: KEUR 8,323). The foreign share of Group sales was 38.4 % compared to 42.8 % in the same period of the previous year.

The consolidated surplus was approx. 18.5 % higher than the previous year at KEUR 8,108 following KEUR 6,840 in 2013. Group results before tax on income improved from KEUR 6,698 in 2013 to KEUR 8,243 (+23.1%). The EBITDA reached KEUR 15,044 following KEUR 13,618 in the previous year (+10.5 %). The EBITA improved by 10.9 % from KEUR 12,744 (2013) to KEUR 14,138. The result per share increased by 14.6
% to 55 cents (2013: 48 cents).

Equity capital improved by 6.0 % as of 31 December 2014 (KEUR 75.812) compared to the previous year (KEUR 71,495). There are no essential bank liabilities. The equity capital rate was 70.1 % (previous year: 71.0 %). Cash fl ow from on-going business operations increased by KEUR 10,544 (2013) to KEUR 11,594 (+10.0%). At the end of 2014, the company had cash resources at its disposal in the amount of KEUR 22,578 (previous year: KEUR 23,804).

At the annual general meeting, the Supervisory Board and the Executive Board will propose to pay a dividend of 13 cents per share.